This Company Wants to Rewrite the Future of Genetic Disease – WIRED

0
58
This Company Wants to Rewrite the Future of Genetic Disease – WIRED

Tessera Therapeutics is developing a new class of gene editors capable of precisely plugging in long stretches of DNA—something that Crispr can’t do.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here